Surgalign's Cortera spinal fixation system received FDA 510(k) clearance, the devicemaker said Aug. 24.
Cortera is Surgalign's new flagship posterior fixation system and has open and minimally invasive modules, according to a company news release. It will be integrated with Surgalign's Holo Portal surgical system, and more implants and instruments are planned for the system in the next three to four years.
The device was developed from inception to clearance in about 16 months, Surgalign President and CEO Terry Rich said in the release.